Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117245373 | 11724537 | 3 | F | 20140613 | 20160709 | 20151111 | 20160721 | EXP | US-ACTELION-A-US2014-101987 | ACTELION | 74.00 | YR | E | M | Y | 0.00000 | 20160721 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117245373 | 11724537 | 1 | PS | TRACLEER | BOSENTAN | 1 | Oral | 125 MG, BID | 281000 | MG | EP098P0101, IP056P0101,EP105P0101 | 21290 | 125 | MG | TABLET | BID | |||
| 117245373 | 11724537 | 2 | C | REVATIO | SILDENAFIL CITRATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117245373 | 11724537 | 1 | Pulmonary hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117245373 | 11724537 | HO |
| 117245373 | 11724537 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117245373 | 11724537 | Chronic obstructive pulmonary disease | |
| 117245373 | 11724537 | Death | |
| 117245373 | 11724537 | Dyspnoea | |
| 117245373 | 11724537 | Fluid retention | |
| 117245373 | 11724537 | Pulmonary arterial hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117245373 | 11724537 | 1 | 20130603 | 20160701 | 0 |